OFFICIAL PUBLICATION OF

by its subsidiary APPco

PBS funding for vigabatrin substitution

Nicholas O’Donoghue 15/09/2023

PBS confirms subsidy arrangements for vigabatrin under a serious scarcity substitution instrument (SSSI) An amendment to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 to enable Pharmaceutical Benefits Scheme (PBS) subsidies for the supply of different forms of vigabatrin under an SSSI. The Therapeutic Goods Administration (TGA) announced

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

PBS funding for vigabatrin substitution

Previous Limited uptake of 60-day scripts

Next Overcoming the language barrier

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Limited uptake of 60-day scripts

Next Overcoming the language barrier

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.